These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29296977)

  • 1. ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint.
    Kekre N; Antin JH
    Blood Adv; 2017 Mar; 1(9):573-576. PubMed ID: 29296977
    [No Abstract]   [Full Text] [Related]  

  • 2. ATG in allogeneic stem cell transplantation: standard of care in 2017? Point.
    Bacigalupo A
    Blood Adv; 2017 Mar; 1(9):569-572. PubMed ID: 29296976
    [No Abstract]   [Full Text] [Related]  

  • 3. Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.
    Shaw BE
    Blood Adv; 2017 Feb; 1(6):401-406. PubMed ID: 29296955
    [No Abstract]   [Full Text] [Related]  

  • 4. Related haploidentical donors are a better choice than matched unrelated donors: Point.
    Fuchs EJ
    Blood Adv; 2017 Feb; 1(6):397-400. PubMed ID: 29296954
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations.
    Kouides PA
    Blood Adv; 2017 Apr; 1(11):699-702. PubMed ID: 29296712
    [No Abstract]   [Full Text] [Related]  

  • 6. Should minimal residual disease negativity be the end point of myeloma therapy?
    Anderson KC
    Blood Adv; 2017 Mar; 1(8):517-521. PubMed ID: 29296970
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets and hemostasis: a new perspective on an old subject.
    Brass LF; Diamond SL; Stalker TJ
    Blood Adv; 2016 Nov; 1(1):5-9. PubMed ID: 29296690
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelets as immune-sensing cells.
    Kapur R; Semple JW
    Blood Adv; 2016 Nov; 1(1):10-14. PubMed ID: 29296691
    [No Abstract]   [Full Text] [Related]  

  • 9. Should minimal residual disease negativity
    Sonneveld P
    Blood Adv; 2017 Mar; 1(8):522-525. PubMed ID: 29296971
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies.
    Jabbour E; Kantarjian H
    Blood Adv; 2016 Dec; 1(3):260-264. PubMed ID: 29296940
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.
    Ragni MV
    Blood Adv; 2017 Apr; 1(11):703-706. PubMed ID: 29296713
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy for acute lymphoblastic leukemia: from famine to feast.
    Davis KL; Mackall CL
    Blood Adv; 2016 Dec; 1(3):265-269. PubMed ID: 29296941
    [No Abstract]   [Full Text] [Related]  

  • 13. Terahertz communication windows and their point-to-point transmission verification: publisher's note.
    Xiao Z; Yang Q; Huang J; Huang Z; Zhou W; Gao Y; Shu R; He Z
    Appl Opt; 2018 Oct; 57(29):8593. PubMed ID: 30461930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing jitter in synchronized time-lens source for coherent Raman scattering imaging: publisher's note.
    Qiu P; Wang K
    Opt Express; 2016 Jan; 24(2):1045. PubMed ID: 26832487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Raman pump power distribution on output spectrum in a multi-wavelength BRFL: publisher's note.
    Mamdoohi G; Sarmani AR; Abu Bakar MH; Mahdi MA
    Opt Express; 2015 Nov; 23(22):29127. PubMed ID: 26561181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease control should be the goal of therapy for WM patients.
    Kastritis E; Dimopoulos MA
    Blood Adv; 2017 Nov; 1(25):2483-2485. PubMed ID: 29296898
    [No Abstract]   [Full Text] [Related]  

  • 18. Publisher's Note: We Changed Page Numbers to Article Numbers for Articles Published in
    Clinics And Practice Editorial Office
    Clin Pract; 2022 Feb; 12(2):147-156. PubMed ID: 35314589
    [No Abstract]   [Full Text] [Related]  

  • 19. Publisher's Note: We Changed Page Numbers to Article Numbers for Articles Published in
    Journal Of Xenobiotics Editorial Office
    J Xenobiot; 2022 Mar; 12(1):53-55. PubMed ID: 35323220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publisher's Note: We Changed Page Numbers to Article Numbers for Articles in
    Neurology International Editorial Office
    Neurol Int; 2022 Mar; 14(1):256-260. PubMed ID: 35324576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.